Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 32

Sort by

Sort Order Select

Journal Articles

The Clinical Utility of Pharmacogenomics Testing in Assessing Tyrosine Kinase Inhibitor Therapy, Intolerance and Responses in Patients with Chronic Myelogenous Leukemia

Blood (2018) 132 (Supplement 1): 5440.

https://doi.org/10.1182/blood-2018-99-118600

Published: 2018

Journal Articles

Use of Next Generation Sequencing Panel for Routine Diagnosis of Hereditary Hemolytic Anemias

Archana M Agarwal, MD, Jay L Patel, MD, Adam Clayton, PhD, Noel Scott Reading, PhD

Blood (2018) 132 (Supplement 1): 2325.

https://doi.org/10.1182/blood-2018-99-112589

Published: 2018

Journal Articles

Precision Medicine for Sickle Cell Disease through Whole Genome Sequencing

Blood (2018) 132 (Supplement 1): 3641.

https://doi.org/10.1182/blood-2018-99-117606

Published: 2018

Journal Articles

UGT1A1 Polymorphism and Mortality Outcome after Allogeneic Stem Cell Transplantation with Busulfan Based Regimen

Patrizia Chiusolo, Angelo Minucci, Metafuni Elisabetta, Sabrina Giammarco, MD PhD, Monica Rossi, Gessica Minnella, Cecilia Zuppi, Andrea Urbani, Andrea Bacigalupo, MD, Ettore Capoluongo, Simona Sica, MD

Blood (2017) 130 (Supplement 1): 3218.

https://doi.org/10.1182/blood.V130.Suppl_1.3218.3218

Published: 2017

Journal Articles

Effects of UGT1A1 Polymorphism, Glucose-6-Phosphate Dehydrogenase Deficiency and Deletional (-3.7кb) α-Thalassemia Among Young Nigerians with Sickle Cell Anemia

Oladele Olatunya, MD, Dulcinéia Martins de Albuquerque, Daniela Pinheiro Leonardo, BS, MSc, Kleber Yotsumoto Fertrin, MD PhD, Adekunle Adekile, MBBS, PhD FMCPaed, FWACP, FRCPCH, FRCP, Fernando Ferreira Costa, MD PhD

Blood (2017) 130 (Supplement 1): 2242.

https://doi.org/10.1182/blood.V130.Suppl_1.2242.2242

Published: 2017

Journal Articles

Mutant Isocitrate Dehydrogenase (mIDH) Inhibitors, Enasidenib or Ivosidenib, in Combination with Azacitidine (AZA): Preliminary Results of a Phase 1b/2 Study in Patients with Newly Diagnosed Acute Myeloid Leukemia (AML)

Courtney D. DiNardo, MDMSc, Anthony S. Stein, MD, Amir T. Fathi, MD MD BS, Pau Montesinos, MD PhD, Olatoyosi Odenike, MD, Hagop M. Kantarjian, MD, Richard M. Stone, MD, Daniel O. Koralek, PhD, Jason Van Oostendorp, M.Sc., Jing Gong, PhD, Ira Gupta, MD, Paresh Vyas, DPhil, FRCP, FRCPath, MRCP, MRCPath

Blood (2017) 130 (Supplement 1): 639.

https://doi.org/10.1182/blood.V130.Suppl_1.639.639

Published: 2017

Journal Articles

Comparison of Clinical Diagnosis for Hereditary Spherocytosis with Molecular Diagnosis By Multi-Gene Target Sequencing in Korea

Hyoung Soo Choi, MD PhD, Qute Choi, MD PhD, Jung Ah Kim, Kyong Ok Im, MT, Si Nae Park, Yoomi Park, Ju Han Kim, MD PhD, Hee Young Shin, MD PhD, Seon Young Kim, MD PhD, Hyoung Jin Kang, MD PhD, Hoon Kook, MD, Soo-Jeong Kim, MD, Inho Kim, MD PhD, Ji Yoon Kim, MD, Hawk Kim, Kyung Duk Park, MD PhD, Kyung Bae Park, MD PhD, Meerim Park, MD PhD, Sang Kyu Park, MD, Eun Sil Park, MD PhD, Jeong-A Park, MD PhD, Ji Kyoung Park, MD, Hee Jo Baek, MD PhD, Jeong Ho Seo, MD, Ye Jee Shim, MD PhD, Hyo Seop Ahn, MD PhD, Keon Hee Yoo, MD PhD, Hoi Soo Yoon, MD PhD, Kun Soo Lee, MD PhD, Kwang Chul Lee, MD PhD, Jae Min Lee, MD, Mee Jeong Lee, MD PhD, Sun Ah Lee, MD, Jun Ah Lee, MD PhD, Jae Hee Lee, MD, Ji Won Lee, MD PhD, Young-Woong Won, MD, Young Tak Lim, MD, Hyun Joo Jung, MD, Hee Won Cheuh, MD PhD, Eun Jin Choi, MD PhD, Hye Lim Jung, MD PhD, Dong Soon Lee, The Hereditary Hemolytic Anemia Working Party of the Korean Society of Hematology

Blood (2016) 128 (22): 1243.

https://doi.org/10.1182/blood.V128.22.1243.1243

Published: 2016

Journal Articles

Using a Next Generation Sequencing Panel to Discover the Obscure Causes of Hereditary Hemolytic Anemias

Archana M Agarwal, MD, N. Scott Reading, PhD, Kimberly Frizzell, PhD, Wei Shen, PhD, Shelly Sorrells, PhD, Mohamed E Salama, MD, Josef T. Prchal, MD, Hassan M. Yaish, Jay L Patel, MD, Robert D. Christensen, MD

Blood (2016) 128 (22): 2433.

https://doi.org/10.1182/blood.V128.22.2433.2433

Published: 2016

Journal Articles

Molecular Diagnosis of Hereditary Spherocytosis By Multi-Gene Target Sequencing in Korea

Qute Choi, MD, Jung Ah Kim, Kyong Ok Im, MT, Si Nae Park, Yoomi Park, Ju Han Kim, Hye Lim Jung, MD PhD, Seon Young Kim, MD PhD, Hee Young Shin, Dong Soon Lee

Blood (2015) 126 (23): 3347.

https://doi.org/10.1182/blood.V126.23.3347.3347

Published: 2015

Journal Articles

The Association of Gilbert's Syndrome with Hyperbilirubinaemia Occurring on Any of Imatinib, Dasatinib and Nilotinib in Patients with Chronic Myeloid Leukaemia (CML)

Jeeyune Bahk, BSc, Simone Claudiani, MD, Richard M Szydlo, BSc, PhD, Sarmad Toma, BSc, Faisal Abdillah, BSc, Sandra Hing, BSc, Simona Deplano, MDPhD, Dragana Milojkovic, Jane F Apperley, MD, Letizia Foroni, MD PhD

Blood (2015) 126 (23): 2795.

https://doi.org/10.1182/blood.V126.23.2795.2795

Published: 2015

Journal Articles

Switching to Nilotinib Are Associated with Deeper Molecular Responses in Chronic Myeloid Leukemia with Persistent Residual Disease on Long-Term Imatinib Therapy: STAT1 Trial in Japan

Chiaki Nakaseko, MD PhD, Naoto Takahashi, MD PhD FJSIM, Kaichi Nishiwaki, MD PhD, Hitoshi Ogasawara, MD PhD, Hisashi Wakita, MD

Blood (2015) 126 (23): 4032.

https://doi.org/10.1182/blood.V126.23.4032.4032

Published: 2015

Journal Articles

Polymorphism of UGT1A1 and Frequency of Hyperbilirubinemia in Patients with Chronic Myeloid Leukemia Treated By Nilotinib

Anastasia Bykova, MD, Adhamjon Abdullaev, MD PhD, Galina Gusarova, MD PhD, Ekaterina Chelysheva, MD PhD, Svetlana Treglazova, MD, Svetlana Smirnova, MD, Anna G. Turkina, MD PhD

Blood (2014) 124 (21): 5538.

https://doi.org/10.1182/blood.V124.21.5538.5538

Published: 2014

Journal Articles

Distinct Associations Between UGT1A1 Gene Promoter Polymorphism and Hyperbilirubinemia in Korean CML Patients Treated with Nilotinib and Radotinib

Soo-Hyun Kim, Soo Young Choi, Sung-Eun Lee, Yun Jeong Oh, Hae Lyun Yoo, Eun-Jung Jang, Mi-yeon Choi, Moon-mi Jang, Hyeoung Joon Kim, MD, Jae-Yong Kwak, MD PhD, Hawk Kim, MD, PhD., Young-Rok Do, PhD, Dong-Wook Kim, MD PhD

Blood (2014) 124 (21): 5511.

https://doi.org/10.1182/blood.V124.21.5511.5511

Published: 2014

Journal Articles

A New Form Of Therapeutic Resistance: Drug Glucuronidation Regulated By The Sonic Hedgehog Factor Gli1

Hiba A Zahreddine, Biljana Culjkovic-Kraljacic, PhD, Sarit Assouline, MD, Abdellatif Amri, Patrick Gendron, M.Sc., Andrea A. Romeo, PhD, Stephen Morris, PhD, James Jaquith, PhD, Gregory Cormack, Eftihia Cocolakis, PhD, Julie Bergeron, MD, Leandro Cerchietti, MD, Brian Leber, MD, Wilson H. Miller, Jr., MD, PhD, Katherine LB. Borden, PhD

Blood (2013) 122 (21): 821.

https://doi.org/10.1182/blood.V122.21.821.821

Published: 2013

Journal Articles

Single Nucleotide Polymorphisms in ABCB1 and CBR1 Predict Toxicity to R-CHOP Type Regimens in Patients with Diffuse Non Hodgkin's Lymphoma

Lars-Petter Jordheim, PhD, Vincent Ribrag, MD, Herve Ghesquieres, MD, PhD, Sophie Pallardy, Richard Delarue, MD, Herve Tilly, Corinne Haioun, MD, PhD, Fabrice Jardin, Gilles Salles, MD, Charles Dumontet, MD, PhD

Blood (2012) 120 (21): 1616.

https://doi.org/10.1182/blood.V120.21.1616.1616

Published: 2012

Journal Articles

Toward Prediction of Thrombosis in Adolescent Girls On Estrogen Containing Contraceptives: Global Coagulation Profiles and Estrogen Gene Polymorphisms.

Ayesha N. Zia, MD, Michael U Callaghan, MD, Anju Sawni, MD, Alcesa Backos, MD, Latha Rao, MD, Meera B. Chitlur, MD, Jeanne M. Lusher, MD, Madhvi Rajpurkar, MD

Blood (2012) 120 (21): 2254.

https://doi.org/10.1182/blood.V120.21.2254.2254

Published: 2012

Journal Articles

Gallstones in a Newborn-Cohort with Sickle Cell Anemia (SCA): Cumulative Risk and Predictive Factors

Annie Kamdem, Cécile Arnaud, Nadia Médejel, Clément Tassel, Isabelle Hau, Serge Pissard, Francoise Bernaudin

Blood (2011) 118 (21): 513.

https://doi.org/10.1182/blood.V118.21.513.513

Published: 2011

Journal Articles

Pharmacogenetic Study of Deferasirox, An Iron Chelating Agent

Hyoung Jin Kang, Ji Won Lee, Ji-Yeob Choi, Nam Hee Kim, Mi Kyung Jang, Chang-Woo Yeo, Sang-Seop Lee, Eun Jong Han, Hyery Kim, Kyung Duk Park, Hee Young Shin, Jae-Gook Shin, Hyo Seop Ahn

Blood (2010) 116 (21): 2060.

https://doi.org/10.1182/blood.V116.21.2060.2060

Published: 2010

Journal Articles

Phenobarbital for Long-Term Management of Marked Hyperbilirubinemia.

A. Majid Shojania, MD

Blood (2009) 114 (22): 5089.

https://doi.org/10.1182/blood.V114.22.5089.5089

Published: 2009

Journal Articles

Pharmacogenetic study in Hodgkin lymphomas reveals the impact of UGT1A1 polymorphisms on patient prognosis

Vincent Ribrag, Serge Koscielny, Olivier Casasnovas, Cecile Cazeneuve, Pauline Brice, Franck Morschhauser, Jean Gabarre, Aspasia Stamatoullas, Gilbert Lenoir, Gilles Salles

Blood (2009) 113 (14): 3307–3313.

https://doi.org/10.1182/blood-2008-03-148874

Published: 2009

NARROW

The Clinical Utility of Pharmacogenomics Testing in Assessing Tyrosine Kinase Inhibitor Therapy, Intolerance and Responses in Patients with Chronic Myelogenous Leukemia

Use of Next Generation Sequencing Panel for Routine Diagnosis of Hereditary Hemolytic Anemias

Precision Medicine for Sickle Cell Disease through Whole Genome Sequencing

UGT1A1 Polymorphism and Mortality Outcome after Allogeneic Stem Cell Transplantation with Busulfan Based Regimen

Effects of UGT1A1 Polymorphism, Glucose-6-Phosphate Dehydrogenase Deficiency and Deletional (-3.7кb) α-Thalassemia Among Young Nigerians with Sickle Cell Anemia

Mutant Isocitrate Dehydrogenase (mIDH) Inhibitors, Enasidenib or Ivosidenib, in Combination with Azacitidine (AZA): Preliminary Results of a Phase 1b/2 Study in Patients with Newly Diagnosed Acute Myeloid Leukemia (AML)

Comparison of Clinical Diagnosis for Hereditary Spherocytosis with Molecular Diagnosis By Multi-Gene Target Sequencing in Korea

Using a Next Generation Sequencing Panel to Discover the Obscure Causes of Hereditary Hemolytic Anemias

Molecular Diagnosis of Hereditary Spherocytosis By Multi-Gene Target Sequencing in Korea

The Association of Gilbert's Syndrome with Hyperbilirubinaemia Occurring on Any of Imatinib, Dasatinib and Nilotinib in Patients with Chronic Myeloid Leukaemia (CML)

Switching to Nilotinib Are Associated with Deeper Molecular Responses in Chronic Myeloid Leukemia with Persistent Residual Disease on Long-Term Imatinib Therapy: STAT1 Trial in Japan

Polymorphism of UGT1A1 and Frequency of Hyperbilirubinemia in Patients with Chronic Myeloid Leukemia Treated By Nilotinib

Distinct Associations Between UGT1A1 Gene Promoter Polymorphism and Hyperbilirubinemia in Korean CML Patients Treated with Nilotinib and Radotinib

A New Form Of Therapeutic Resistance: Drug Glucuronidation Regulated By The Sonic Hedgehog Factor Gli1

Single Nucleotide Polymorphisms in ABCB1 and CBR1 Predict Toxicity to R-CHOP Type Regimens in Patients with Diffuse Non Hodgkin's Lymphoma

Toward Prediction of Thrombosis in Adolescent Girls On Estrogen Containing Contraceptives: Global Coagulation Profiles and Estrogen Gene Polymorphisms.

Gallstones in a Newborn-Cohort with Sickle Cell Anemia (SCA): Cumulative Risk and Predictive Factors

Pharmacogenetic Study of Deferasirox, An Iron Chelating Agent

Phenobarbital for Long-Term Management of Marked Hyperbilirubinemia.

Pharmacogenetic study in Hodgkin lymphomas reveals the impact of UGT1A1 polymorphisms on patient prognosis

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only